Godavari Biorefineries Ltd
Incorporated in 1939, Godavari Biorefineries Ltd is a manufacturer of Bio-based Chemicals and Ethanol[1]
- Market Cap ₹ 859 Cr.
- Current Price ₹ 168
- High / Low ₹ 409 / 166
- Stock P/E 69.3
- Book Value ₹ 78.1
- Dividend Yield 0.00 %
- ROCE 7.40 %
- ROE 2.50 %
- Face Value ₹ 10.0
Pros
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Company has low interest coverage ratio.
- Tax rate seems low
- Company has a low return on equity of 3.64% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| 1,459 | 1,538 | 1,702 | 2,015 | 1,687 | |
| 1,356 | 1,381 | 1,568 | 1,867 | 1,553 | |
| Operating Profit | 103 | 158 | 135 | 147 | 134 |
| OPM % | 7% | 10% | 8% | 7% | 8% |
| 14 | 8 | 6 | 7 | 14 | |
| Interest | 69 | 72 | 60 | 73 | 76 |
| Depreciation | 45 | 47 | 48 | 50 | 60 |
| Profit before tax | 3 | 46 | 33 | 32 | 12 |
| Tax % | -24% | 41% | 40% | 38% | 1% |
| 4 | 27 | 19 | 20 | 12 | |
| EPS in Rs | 0.97 | 6.47 | 4.64 | 4.68 | 2.93 |
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 3% |
| TTM: | -16% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -22% |
| TTM: | -39% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 4% |
| Last Year: | 3% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
|---|---|---|---|---|---|---|
| Equity Capital | 42 | 42 | 42 | 42 | 42 | 42 |
| Reserves | 385 | 412 | 431 | 448 | 459 | 358 |
| 589 | 569 | 637 | 736 | 655 | 685 | |
| 418 | 419 | 623 | 518 | 836 | 271 | |
| Total Liabilities | 1,434 | 1,442 | 1,733 | 1,744 | 1,992 | 1,356 |
| 735 | 708 | 667 | 866 | 850 | 845 | |
| CWIP | 17 | 9 | 50 | 17 | 29 | 33 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| 683 | 725 | 1,016 | 860 | 1,113 | 478 | |
| Total Assets | 1,434 | 1,442 | 1,733 | 1,744 | 1,992 | 1,356 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| 250 | 130 | 45 | 197 | 186 | |
| -23 | -7 | -47 | -214 | -44 | |
| -226 | -121 | 4 | 28 | -151 | |
| Net Cash Flow | 1 | 2 | 3 | 11 | -10 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Debtor Days | 31 | 40 | 39 | 37 | 41 |
| Inventory Days | 130 | 146 | 200 | 137 | 250 |
| Days Payable | 123 | 132 | 176 | 105 | 195 |
| Cash Conversion Cycle | 39 | 55 | 63 | 68 | 95 |
| Working Capital Days | 44 | 57 | 72 | 52 | 50 |
| ROCE % | 12% | 9% | 9% | 7% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
17 Feb - Earning Call Transcript held on 10th February, 2025
-
Announcement under Regulation 30 (LODR)-Monitoring Agency Report
13 Feb - Monitoring Agency report on IPO proceeds utilization.
-
Compliance Under Regulation 32-Statement Of Deviation And Varriation
12 Feb - Statement confirming no deviation in IPO fund utilization.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
10 Feb - Audio recording of Q3 earnings conference call uploaded.
-
Announcement under Regulation 30 (LODR)-Investor Presentation
10 Feb - Invstor presentation related with Q39MFY25 financial Results
Concalls
-
Feb 2025Transcript PPT REC
-
Nov 2024Transcript PPT REC
Business Overview:[1][2]
a) GBL is a part of the Somaiya group which holds 63.31% equity stake in the company through entities.
b) It has an Integrated Bio-refinery across value chain viz. Sugar, Branded Sugar, Ethanol, Bio Based Chemicals & Power
c) It has India’s first bio-based Ethyl Vinyl Ether (EVE) manufacturing facility in India
d) Company is the largest Manufacturer of MPO in India in terms of installed capacity
e) It is one of only 2 Manufacturers of natural 1,3 Butylene Glycol (BG) globally
f) The company has an in-house retail brand Jivana for sale of sugar, turmeric, and salt in Rajasthan Maharashtra, Karnataka, and Gujarat.